ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

Japan approval for remdesivir expected 'soon,' Abe says

Antiviral drug will receive fast-track status if certified by another nation

Prime Minister Shinzo Abe speaks in the Diet parliamentary building in Tokyo on April 27. (Photo by Uichiro Kasai)

TOKYO -- Japan is on the verge of initiating a fast-track approval process for Gilead Sciences' antiviral drug remdesivir to treat patients infected by the novel coronavirus, Prime Minister Shinzo Abe said Monday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more